Table 2.
Descriptive Statistics (Dose, Age, BMI)
| Cumulative Drug Dose | Final Effect Site Concentration | Age | BMI | |
|---|---|---|---|---|
|
|
||||
| Dexmedetomidine | 0.5 (0.2) mg | 26.2 (8.2) ng/ml | 24.8 (6.3) yrs | 25.1 (4.8) kg/m2 |
| Midazolam | 4.4 (2.2) mg | 87.9 (43.9) ng/ml | 23.9 (4.4) yrs | 27.7 (5.6) kg/m2 |
| Propofol | 186 (77.5) mg | 93.0 (38.8) mcg/ml | 28.4 (5.4) yrs | 26.1 (3.5) kg/m2 |
| Control | NA | NA | 26.5 (5.1) yrs | 22.8 (2.7) kg/m2 |
Data presented as means and standard deviation, provided in parenthesis. Cumulative Drug Dose refers to the sedative dose administered to a participant over the course of the study. Final Effect Site Concentration refers to the effect site concentration of sedation drug at the end of the fMRI scan under sedation. BMI … body mass index. yrs … years.